Lasik Xtra®

Enhancing LASIK

Performed in conjunction with LASIK, the Lasik Xtra procedure enhances the corneal biomechanical integrity. Lasik Xtra poses no material interruption to the normal speed and flow of the LASIK procedure and does not increase patient discomfort.

A patient and doctor with the KXL® system for performing cross-linking and Lasik Xtra®.
A patient and doctor with the KXL® system for performing cross-linking and Lasik Xtra®.

Who can benefit from Lasik Xtra?

LASIK patients:

When the flap is created during a standard LASIK procedure, the structural integrity of the cornea can be weakened by up to 33% depending on the thickness of the flap.1 Lasik Xtra has the ability to strengthen a cornea that may have been compromised during LASIK, restoring the biomechanical integrity of the eye.

How it works

After the refractive correction has been made in a standard LASIK procedure, the Glaukos riboflavin formulation, VibeX Xtra™, is applied to the exposed stroma and the flap is replaced. UVA illumination from the KXL® system is then applied through the intact epithelium for approximately 90 seconds.

Lasik Xtra®

Lasik Xtra Video

Watch Video

Combining Corneal Cross-Linking with LASIK

Combining Cross-Linking Article

By Lim Li, MD, The Ophthalmologist (September 2019)

Read Now


  • Jaycock PD, Lobo L, Ibrahim J, Tyrer J, Marshall J. Interferometric technique to measure biomechanical changes in the cornea induced by refractive surgery. J Cataract Refract Surg. 2005;31(1):175-184.

We want to hear from you!

Please contact us to learn more about our cross-linking products and procedures.

Contact Us

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Please Select Your Country


Intended Use

The KXL® System is intended for illuminating the cornea during corneal cross-linking procedures stabilizing cornea which have been weakened by disease or by refractive surgery.

Safety Information

The KXL® System is contraindicated where the corneal thickness, with epithelium, is less than < 375 microns, in corneal melting disorders, aphakic patients, pseudophakic patients without UV blocking lens implanted, pregnant and nursing women, and children. Possible risks may include corneal haze, delayed epithelial healing, corneal edema, stromal scarring, keratitis by infection and sterile infiltrates. For full information consult the directions for use.